Evidence map›Paper›PMID 27994057›Full record

ArticleThe Journal of biological chemistry2017

FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage.

Carolina L Bigarella, Jianfeng Li, Pauline Rimmelé, Raymond Liang, Robert W Sobol, Saghi Ghaffari

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Metabolomics of healthy hematopoietic stem cells and leukemic stem cells.Journal of clinical and translational research · 2025
    Article
  6. Article
  7. DAF-16/FOXO maintains genome integrity following genotoxic stress.bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Carolina L BigarellaFrom the Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Jianfeng Lithe Department of Oncologic Sciences, University of South Alabama Mitchell Cancer Institute, Mobile, Alabama 36604.
Pauline RimmeléFrom the Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Raymond LiangFrom the Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Robert W Sobolthe Department of Oncologic Sciences, University of South Alabama Mitchell Cancer Institute, Mobile, Alabama 36604.
Saghi GhaffariFrom the Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, saghi.ghaffari@mssm.edu.
Icahn School of Medicine at Mount Sinai · USStem Cell Institute · PAUniversity of South Alabama · USUSA Mitchell Cancer Institute · US

Funding

(PQ5) Mitochondria in Leukemic Stem Cell Disease ProgressionR01CA205975 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GHAFFARI, SAGHI · 2016 to 2025
$3.9M
Novel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4M
Novel Determinants of Terminal Erythroid MaturationR01HL116365 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BRESNICK, EMERY H, GHAFFARI, SAGHI · 2012 to 2015
$1.6M
Quantitative Real-Time DNA Repair Analysis ToolsR43ES025138 · NIEHS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2014 to 2014
$202k
NCI NIH HHS R01 CA148629NCI NIH HHS R01 CA205975NHLBI NIH HHS R01 HL116365NIEHS NIH HHS R43 ES025138
6 · The paper itself

Abstract

Accumulation of damaged DNA in hematopoietic stem cells (HSC) is associated with chromosomal abnormalities, genomic instability, and HSC aging and might promote hematological malignancies with age. Despite this, the regulatory pathways implicated in the HSC DNA damage response have not been fully elucidated. One of the sources of DNA damage is reactive oxygen species (ROS) generated by both exogenous and endogenous insults. Balancing ROS levels in HSC requires FOXO3, which is an essential transcription factor for HSC maintenance implicated in HSC aging. Elevated ROS levels result in defective

Indexed as

DNA DamageOxidative StressAcetylcysteineAnimalsCell CycleForkhead Box Protein O3Hematopoietic Stem CellsMiceMice, Inbred C57BLReactive Oxygen SpeciesAcetylcysteineForkhead Box Protein O3FoxO3 protein, mouseReactive Oxygen Speciesagingbase excision repair (BER)DNA damage responseFOXOFOXO3hematopoietic stem cellsoxidative DNA damageoxidative stressreactive oxygen species (ROS)ROS

Identifiers

PMID27994057
PMCPMC5314194
OpenAlexW2567146478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.